Peer-reviewedLicence not statedGlobal Health & Medicine
First reported clinical implementation of pressurized intraperitoneal aerosol chemotherapy in Japan: Program development and 30-day outcomes in two patients
7 affiliations
- 1Peritoneal Malignancy Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan
- 2Department of Surgical Oncology, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan
- 3Department of Anesthesiology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan
- 4Central Operating Theater, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan
- 5Radiological Physics and Technology Department, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan
- 6Pharmaceutical Department, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan
- 7Japan Institute for Health Security, Tokyo, Japan.
Related
- Anesthetic management of a child undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent embryonal rhabdomyosarcoma: A case report.
- Preoperative inspiratory muscle training for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized feasibility study
- Patient-reported Symptom Resolution After Neoadjuvant Versus Adjuvant Chemotherapy for Early Breast Cancer: A Prospective Observational Cohort Study
- Quality of Life and Patient-Reported Outcomes During First-Line Chemotherapy in Older Patients with De Novo Metastatic Gastrointestinal Cancers: A Prospective Longitudinal Study.
- Real-world patient-reported outcome comparing antibody-drug conjugates and conventional chemotherapy in metastatic breast cancer.
BibTeX
@article{takeuchi2026first,
title = {{First reported clinical implementation of pressurized intraperitoneal aerosol chemotherapy in Japan: Program development and 30-day outcomes in two patients}},
author = {Hiroshi Takeuchi and Yoshimasa Gohda and Joji Kitayama and Takako Kato and Yui Hieda and Hironao Shimano and Hiroshi Kudo and Norihiro Kokudo},
journal = {Global Health \& Medicine},
year = {2026},
month = oct,
doi = {10.35772/ghm.2026.01111},
url = {https://doi.org/10.35772/ghm.2026.01111},
}
RIS
TY - JOUR
TI - First reported clinical implementation of pressurized intraperitoneal aerosol chemotherapy in Japan: Program development and 30-day outcomes in two patients
AU - Hiroshi Takeuchi
AU - Yoshimasa Gohda
AU - Joji Kitayama
AU - Takako Kato
AU - Yui Hieda
AU - Hironao Shimano
AU - Hiroshi Kudo
AU - Norihiro Kokudo
PY - 2026
DA - 2026/10/31
JO - Global Health & Medicine
DO - 10.35772/ghm.2026.01111
UR - https://doi.org/10.35772/ghm.2026.01111
SN - 2434-9186
SN - 2434-9194
ER -